forum

INDRAMEDCO Share Price Discussion

Indraprastha Medical Corporation Ltd.
Sector: Pharmaceuticals and health care
... Read more
INDRAMEDCO Share Price *
37.35 +0 (0%)
* (quote may be delayed)

INDRAMEDCO Discussion Forum

Indraprastha Standalone June 2019 Net Sales at Rs 203.69 crore, up 7.56% Y-o-Y
moneycontrol.com
Like
reply
Reply
share
Share
Like
reply
Reply
share
Share
Like
reply
Reply
share
Share
  • INDRAMEDCO - Share Price - Fundamentals

    keyboard_arrow_down
    Market Capitalization442.77
    Enterprise Value500.39
    Price to Earnings20.98
    Price to Book Value1.91
    Return on Capital Employed0.14
    Return on Equity0.09
    Face Value10
    Dividend Yield0.03
  • INDRAMEDCO Share Price - Technicals

    keyboard_arrow_down
    INDRAMEDCO - 52 Week High₹46
    INDRAMEDCO - 52 Week Low₹35.1
  • INDRAMEDCO Share Price - Historical (₹)

    keyboard_arrow_down
    DateOpenHighLowClose
    Sep 1637.437.7537.1537.2
    Sep 1337.5538.337.337.35
    Sep 1237.2538.536.938.2
    Sep 1138.138.737.9538.45
    Sep 938.138.2537.137.95
  • INDRAMEDCO Share Price - Daily Moving Averages (DMA)

    keyboard_arrow_down
    20 Day Moving Average₹36.92
    30 Day Moving Average₹36.62
    50 Day Moving Average₹36.68
    100 Day Moving Average₹37.51
    200 Day Moving Average₹38.16
  • INDRAMEDCO - Profit And Loss

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17 % Change
    Revenue748.36765.72-0.02
    Operating Profit71.9977.67-0.07
    Profit Before Tax34.0140.82-0.17
    Net Income21.126.25-0.2
  • INDRAMEDCO - Balance Sheet

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17 % Change
    Shareholder's Funds232.31230.820.01
    Total Liabilities214.04269.72-0.21
    Total Assets446.35500.54-0.11
  • INDRAMEDCO - Cash Flow

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17 % Change
    Cash from Operating Activity47.728.390.68
    Cash from Investing Activity-29.9-22.40.33
    Cash from Financing Activity-17.22-5.392.19
    Net Cash Flow0.580.6-0.03
  • INDRAMEDCO - Ratios

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17
    Return on Assets0.050.05
    Return on Equity0.090.11
    Return on Capital Employed0.140.16
  • INDRAMEDCO - 3 year Growth

    keyboard_arrow_down
    3 Year CAGR Growth in Revenue0.05
    3 Year CAGR Growth in Operating Profit-0.15
    3 Year CAGR Growth in EBIDTA-0.14
    3 Year CAGR Growth in Net Income-0.35
    3 Yr CAGR Growth - Diluted EPS-0.35
  • INDRAMEDCO - 5 year Growth

    keyboard_arrow_down
    5 Year CAGR Growth in Revenue0.23
    5 Year CAGR Growth in Operating Profit-0.08
    5 Year CAGR Growth in EBIDTA-0.08
    5 Year CAGR Growth in Net Income-0.27
    3 Yr CAGR Growth - Diluted EPS-0.27
  • INDRAMEDCO Share Price - Recent News

    keyboard_arrow_down
    NewsBot
    Jul 29 6:38 PM
    Indraprastha Standalone June 2019 Net Sales at Rs 203.69 crore, up 7.56% Y-o-Y
    moneycontrol.com
    NewsBot
    Jun 17 1:13 PM
    NewsBot
    Jun 17 12:58 AM
    NewsBot
    Jan 30 11:12 PM
    NewsBot
    Nov 13 5:22 PM
  • INDRAMEDCO - Related Communities

    keyboard_arrow_down
    Sakar Healthcare Ltd. Sector: Pharmac...
    Metropolis Healthcare Ltd. Sector: Ph...
    Vimta Labs Ltd. Sector: Pharmaceutica...
    Thyrocare Technologies Ltd. Sector: P...
    Shalby Ltd. Sector: Pharmaceuticals a...
    Narayana Hrudayalaya Ltd. Sector: Pha...
    Lotus Eye Hospital and Institute Ltd....
    Dr. Lal Pathlabs Ltd. Sector: Pharmac...
    Indraprastha Medical Corporation Ltd....
    Healthcare Global Enterprises Ltd. Se...
SOURCE: Data from D'Market via Quandl. Intraday data delayed 15 minutes.
DISCLAIMER: Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.